485
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Inhaled prostanoid therapy for pulmonary arterial hypertension – a promise unfulfilled?

, MD
Pages 923-925 | Published online: 20 Apr 2012

Bibliography

  • Barst RJ, Rubin LJ, Long WA, A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The primary pulmonary hypertension study group. N Engl J Med 1996;334:296-302
  • McClaughlin VV, Archer SL, Badesch DB, ACCF/AHA 2009 Expert Consensus Document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert consensus Documents and the American Heart Association Developed in Collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol 2009;53:1573-619
  • Gibbs JSR. Treating pulmonary arterial hypertension: is it worth it? Heart 2010;96:1607-8
  • White JR, Ferrantino M. Inhaled treprostinil sodium for the treatment of pulmonary arterial hypertension. Expert Opin Pharmacother 2011;12:2583-93
  • Hiremath J, Thanikachalam S, Parik K, Exercise improvement and plasma biomarker changes with intravenous treprostinil therapy for pulmonary arterial hypertension: a placebo-controlled trial. J Heart Lung Transplant 2010;29:137-40
  • Lang I, Gomez-Sanchez M, Kneussl M, Efficacy of long term subcutaneous treprostinil sodium therapy in pulmonary hypertension. Chest 2006;129:1636-43
  • Weintraub A. Pfizer's Exubera flop. 18 October 2007. Available from: http://www.businessweek.com/technology/content/oct2007/tc20071018_028695.htm. (Last accessed on January 14, 2012)
  • Olschewski H, Simonneau G, Galie N, Inahled iloprost for severe primary pulmonary hypertension. N Engl J Med 2002;347:322-9
  • McLaughlin VV, Benza RL, Rubin LJ, Additional of inhaled treprostinil to oral therapy for pulmonary arterial hypertension. J Am Coll Cardiol 2010;55:1015-22
  • McLaughlin VV, Oudiz RJ, Frost A, Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension. Am J Respir Crit Care Med 2006;174:1257-63
  • Bourge RC, Tapson VF, Safdar Z, Transitioning patients from inhaled iloprost to inhaled treprostinil sodium: an interim analysis. Am J Respir Crit Care Med 2010;181:A3342. Abstract

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.